{"query_echo":{"q":"","filters":{"analysis_type":["public health investigation"]},"warnings":[{"code":"facet_value_not_in_vocabulary","message":"Value 'public health investigation' for facet 'analysis_type' is not in the controlled vocabulary."}]},"total":{"value":1,"relation":"eq"},"page":1,"page_size":20,"self":"https://climateinsightsdirectory.org/api/v1/search?analysis_type=public+health+investigation","stability":"beta","ai_marking":{"digital_source_type":{"uri":"http://cv.iptc.org/newscodes/digitalsourcetype/trainedAlgorithmicMedia","name":"Created using Generative AI"},"notice":"Summary and key insights are generated using artificial intelligence."},"results":[{"id":"chanmar-000181","url":"https://climateinsightsdirectory.org/document/chanmar-000181","title":"IMPACTS OF PHARMACEUTICAL POLLUTION ON COMMUNITIES AND ENVIRONMENT IN INDIA","publisher":{"name":"Changing Markets Foundation","organization":"changing-markets-foundation"},"document_type":"report","language":"en","date_published":"2016-02","source_url":"https://changingmarkets.org/wp-content/uploads/2023/10/Impacts-of-pharmaceutical-pollution-on-communities-and-environment-in-India-WEB-light.pdf","generator":"Climate Insights Directory","generated_fields":["summary","key_insights","climate_tags","geography_discussed","analysis_type"],"summary":{"text":"The report documents systematic pharmaceutical pollution in India, particularly in the bulk drug manufacturing hubs of Hyderabad and Visakhapatnam. It argues that the discharge of active pharmaceutical ingredients (APIs) into waterways contributes to the global threat of antimicrobial resistance (AMR) and causes severe local health and environmental degradation. The document highlights a failure of regulatory oversight and a lack of supply chain transparency, which allows multinational pharmaceutical companies to outsource production to polluting sites without accountability. It recommends integrating environmental standards into the Good Manufacturing Practice (GMP) framework and increasing transparency in supplier relationships.","ai_generated":true,"unit":"chanmar-000181#summary","date_modified":"2026-10-23"},"key_insights":[{"text":"Pharmaceutical manufacturing in India, particularly the bulk drug sector in Hyderabad and Visakhapatnam, has caused extreme contamination of waterways and agricultural lands, leading to severe health issues for local inhabitants including miscarriages, cancers, and skin diseases.","ai_generated":true,"unit":"chanmar-000181#insight-1","date_modified":"2026-10-23"},{"text":"The discharge of antibiotic residues from manufacturing plants into the environment is a significant driver of antimicrobial resistance (AMR), creating a global public health threat as resistance genes spread through travel and trade.","ai_generated":true,"unit":"chanmar-000181#insight-2","date_modified":"2026-10-23"},{"text":"Effluent treatment systems in Hyderabad, such as the Patancheru Common Effluent Treatment Plant (CETP) and the Amberpet Sewage Treatment Plant (STP), are described as dysfunctional and unfit for purpose, often resulting in the discharge of untreated chemical waste into the Musi River.","ai_generated":true,"unit":"chanmar-000181#insight-3","date_modified":"2026-10-23"},{"text":"There is a profound lack of transparency in pharmaceutical supply chains, which prevents the identification of the multinational companies purchasing drugs from polluting Indian factories.","ai_generated":true,"unit":"chanmar-000181#insight-4","date_modified":"2026-10-23"},{"text":"Regulatory oversight in India is characterized by industry capture and corruption, with pollution control boards often failing to enforce standards or ignoring illegal dumping by tankers.","ai_generated":true,"unit":"chanmar-000181#insight-5","date_modified":"2026-10-23"},{"text":"The report identifies several major pharmaceutical companies as significant polluters in the region, including Aurobindo, Dr Reddy’s, Hetero Drugs Ltd, and Mylan Laboratories Ltd.","ai_generated":true,"unit":"chanmar-000181#insight-6","date_modified":"2026-10-23"},{"text":"The Good Manufacturing Practice (GMP) framework, used by the US FDA and EU to monitor drug safety, currently lacks provisions to regulate environmental emissions, meaning factories can be approved for safety while continuing to pollute.","ai_generated":true,"unit":"chanmar-000181#insight-7","date_modified":"2026-10-23"},{"text":"In Visakhapatnam, the Jawaharlal Nehru Pharma City (JNPC) has been linked to adverse health effects and the contamination of coastal waters and the Bay of Bengal, impacting local fishing livelihoods.","ai_generated":true,"unit":"chanmar-000181#insight-8","date_modified":"2026-10-23"}],"climate_tags":["water pollution","Global supply chain governance","public health"],"geography_discussed":["Telangana","Andhra Pradesh","People's Republic of China","Sweden","European Union","United States","Malta"],"frame_perspective":[],"analysis_type":["environmental assessment","public health investigation","supply chain analysis"]}]}